Gene-specific compounds to lead development of anti-cancer drugs

11/28/2004 | Guardian (London), The

Thousands of new drug compounds will be available within the next six years for treating cancer, saving the lives of millions but increasing the National Health Service's drugs outlay, a U.K. newspaper concludes. Many of the new drugs expected to be created by 2010 will be aimed at genetic tumor abnormalities, according to The Observer's investigation.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA